Quote:What the president said he did on the virus — and what he actually did
A list of his key moves released by Trump's campaign overstates some of his actions – and leaves out the inactions.
https://www.politico.com/news/2020/04/14/what...rus-186464
By TUCKER DOHERTY
04/14/2020 08:05 PM EDT
President Donald Trump, stung by accusations that he was slow to act on the coronavirus pandemic, has released a long list of key actions the administration took to save lives.
But the list, released by his campaign, overstates some of his actions – and leaves out the inactions.
The Centers for Disease Control did distribute tests, as the White House notes. But it omitted that the tests didn’t work – and even when they did get improved, testing capacity lagged way behind the need.
It was during these crucial weeks, many public health experts say, that an initial scattering of infections snowballed into deadly hot spots. The president highlighted how he sought to get American CDC experts into China, while omitting that he had earlier cut back the U.S. engagement there. He did take action on vaccine development, which arguably helped.
Here’s all the ways the president said he took action – coupled with a reality check for what really happened
Testing
Trump's Timeline
February 6: The CDC began shipping CDC-developed test kits for the 2019 Novel Coronavirus to U.S. and international labs.
February 12: The U.S. shipped test kits for the 2019 novel coronavirus to approximately 30 countries who lacked the necessary reagents and other materials.
February 14: The CDC began working with five labs to conduct “community-based influenza surveillance” to study and detect the spread of coronavirus.
February 29 : The Food and Drug Administration (FDA) allowed certified labs to develop and begin testing coronavirus testing kits while reviewing pending applications.
Reality Check
The CDC admits that the test kits deployed early on in the crisis were deeply flawed, preventing widespread use and hobbling U.S. testing capacity. Two weeks after the initial announcement, just three of the more than 100 public health labs in the U.S. had verified the CDC test for use, according to the Association of Public Health Laboratories.
For more than three weeks, the federal government insisted that only CDC-developed tests could be legally used to identify coronavirus outbreaks. The kits’ failures left states dependent on mailed samples to the CDC’s central lab --which proved to be a major bottleneck, delaying results.
Moreover, the testing flaws delayed deployment of the touted “community-based influenza surveillance,” a potential early warning system for hot spots. At the time, former FDA Commissioner Scott Gottlieb told POLITICO that the testing delay could impede the government’s ability to detect scattered cases before they fueled larger outbreaks.
The eventual solution — a shift in FDA policy that let labs develop and deploy their own tests, beginning on Feb 29 — came nearly a week after APHL urgently requested the regulatory relief.
Britta Jewell, an epidemiologist at Imperial College, London, told POLITICO that the lack of early and widespread testing in the U.S. played an important role in the timing of social distancing policies. Her work suggests that implementing the policies two weeks earlier could have reduced coronavirus deaths tenfold.
“Many countries – not just the U.S. – were understandably trying to time social distancing policies to minimize economic pain,” Britta said, “But it’s very difficult to get the timing right if you don’t know with reasonable confidence where the hot spots are or how many people are infected.”
China Monitoring
Trump's Timeline
February 3: The CDC had a team ready to travel to China to obtain critical information on the novel coronavirus, but were in the U.S. awaiting permission to enter by the Chinese government.
February 7: President Trump told reporters that the CDC is working with China on the coronavirus.
February 12: The CDC was prepared to travel to China but had yet to receive permission from the Chinese government.
February 22: A WHO team of international experts arrives in Wuhan, China.
Reality Check
The document accurately notes that China prevented CDC and WHO experts from assessing the outbreak in early February. But it omits context – cuts to international public health efforts by the Trump administration prior to the pandemic had left a smaller footprint in China.
According to reports by Reuters, the administration eliminated a public health position in Beijing last July that had embedded an American epidemiologist in China’s disease control agency. More broadly, the CDC has cut dozens of China-based positions since Trump took office.
The briefings aren’t working: Trump’s approval rating takes a dip
Stanley Chera, friend of President Trump, dies of coronavirus
CDC denies that the reduced American presence affected its assessments of the pandemic threat.
U.S. intelligence agencies were also issuing their own classified warnings in January and February about the global danger posed by the virus and attempts by Chinese officials to minimize the apparent severity.
Public Communications
Trump's Timeline
February 4: President Trump vowed in his State of the Union Address to “take all necessary steps” to protect Americans from the coronavirus.
February 9: The White House Coronavirus Task Force briefed governors from across the nation at the National Governors’ Association Meeting in Washington.
February 24: The Trump Administration sent a letter to Congress requesting at least $2.5 billion to help combat the spread of the coronavirus.
February 26: President Trump discussed coronavirus containment efforts with Indian PM Modi and updated the press on his Administration’s containment efforts in the U.S. during his state visit to India.
Reality Check
While technically accurate, the campaign’s descriptions omit the fact that Trump’s public statements throughout February repeatedly downplayed the pandemic.
While the White House Coronavirus Task Force did provide a briefing at the National Governors’ Association meeting, the panel stated that "the risk to the American public remains low at this time,” according to a summary released by HHS. Likewise, during the touted press briefing in India, Trump incorrectly stated that the virus was "very well under control in our country" and claimed the “whole situation will start working out.”
The White House letter to Congress did request $2.5 billion, although $535 million was redirected from Ebola prevention and treatment. Ultimately, after weeks of negotiation, Congress passed a $2 trillion relief package in late March with more than $120 billion in public health funding.
Vaccine Production
Trump's Timeline
February 11: The Department of Health and Human Services (HHS) expanded a partnership with Janssen Research & Development to “expedite the development” of a coronavirus vaccine.
February 18: HHS announced it would engage with Sanofi Pasteur in an effort to quickly develop a coronavirus vaccine and to develop treatment for coronavirus infections.
Reality Check
The vaccine partnerships are moving forward, and public health experts say the federal government’s financial backing could help expedite a vaccine.
But Trump has repeatedly overestimated and overpromised how quickly a vaccine could be deployed. Optimistically, researchers say a vaccine could be ready after a year to 18 months of development and testing. But it would take more time to ramp up production.
Experts say a more immediate need was more production of personal protective equipment for health workers on the front lines. The list makes no mention of actions to accelerate that production until late March.
Travel Restrictions
Trump's Timeline
February 29: The Trump Administration:
- Announced a level 4 travel advisory to areas of Italy and South Korea
- Barred all travel to Iran
- Barred the entry of foreign citizens who visited Iran in the last 14 days
Reality Check
Trump frequently defends his record by pointing to China travel restrictions announced on January 31, a move broadly defended by public health experts despite significant gaps.
Further efforts to contain travel from other countries, once the virus had escaped China and gained footholds throughout Europe and Asia, didn’t come until the end of February.
By then, strains of the virus originating in Europe were likely already circulating throughout New York City. Trump issued a comprehensive set of European travel restrictions on March 11. Experts say Iran was likely an early hot spot, although data on the virus’ spread in that country is limited.
While travel restrictions are a widely accepted tool for containing international disease outbreaks, some experts have criticized the focus on foreign travelers – noting that American citizens are no less likely to contract the disease and spread it upon their return.
While returning citizens are typically screened at airports, many have gone home with little more than an information pamphlet and instructions to self-quarantine. In contrast, Hong Kong – touted by some public health experts as a model international response – has run random saliva tests and subjected nearly all travelers to mandatory 14-day quarantines with criminal penalties for disobeying.
What the president said he did on the virus — and what he
Top 10 Most Recent News Articles
Cancer Memoir Shows Healing Beyond Medicine
Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...
Continue Reading
Community Heritage Financial Declares Q3 2026 Dividend
Dividend Declared Amidst Challenging Times There's nothing quite like the ringing of a cash register, and for Community Heritage Financial, Inc. (OTCID: CMHF), that's what an $0.08 per share dividend feels like. Declared for the third quarter of 2026, this payout is set to line the pockets of shareholders who made the cut by October 30, 2026. The folks waiting for their...
Continue Reading
Coastal Financial Faces Lawsuit Over Fraud Allegations
Coastal Financial Corporation, riding high on NASDAQ as CCB, now finds itself in the middle of a storm. Schall, Brown & Schwartz LLP, a firm known for its shareholder rights litigation, has thrown the gauntlet with a class action lawsuit against Coastal for suspected securities violations. We're talking about potential fibs under Section 10(b) and 20(a) of the Securities...
Continue Reading
Honeywell Aerospace Faces Securities Fraud Lawsuit
Turning Up the Heat on Honeywell Alright, strap in because things are getting tense over at Honeywell Aerospace (NASDAQ:HONA). Schall, Brown & Schwartz LLP (SBS) is stirring the pot with a class action lawsuit alleging some pretty deceptive business going-ons. From securities violations to misleading market statements, they aren’t holding back any punches. What’s This...
Continue Reading
Understanding Truck Accident Settlements in Memphis
Delving into Truck Accident Settlement Timelines Out there in Memphis, timing a truck accident settlement isn't exactly like clockwork work. When it comes to getting your compensation, the timeline varies as widely as a duck hunting trip—sometimes you come home with a basketful, sometimes it’s empty. It might be a quick couple of months or drag on past a year, and...
Continue Reading
Alaska LNG Project Boosted by Strategic Positioning
Alaska LNG: Right Place, Right Time Someone bring out the confetti, because Paul Sullivan, Co-Chairman of Gastech, is celebrating Alaska LNG like it's 1999. And for good reason. If Alaska ever played its cards right, now's the moment according to the industry veteran. After Gastech 2026 wrapped its events in Bangkok last month, Sullivan laid out why the stars are aligning...
Continue Reading
LINC Lawsuit: Boardroom Stumbles Spark Investor Action
Class Action Kickoff: Lincoln's Educational Curveball No one fancies home runs when the ball’s out of sight, and that’s probably how some investors in Lincoln Educational Services Corporation (NASDAQ: LINC) are feeling right now. A group of shareholders has pulled back the curtain on what they believe are more than just administrative hiccups—allegations of...
Continue Reading
Alpha Rising Joins RFP: A Strong AI-Fueled Expansion
The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...
Continue Reading
Workday Hits High Note in 2026 Gartner Magic Quadrant
Workday Secures Leadership Position In a wild ride that's left investors with whiplash in recent years, Workday (NASDAQ: WDAY) has firmly planted its flag at the top tier of the 2026 Gartner® Magic Quadrant™ for Cloud ERP Finance. This announcement out of Pleasanton, California, resonates like a victory bell for the company's finance management solutions—a mix of AI,...
Continue Reading
F.N.B. Q3 2026 Earnings: Solid Growth Continues
F.N.B. Stays the Course with Strong Q3 2026 Ever heard the phrase “slow and steady wins the race?” That seems to be the mantra over at F.N.B. Corporation (NYSE: FNB) as they roll out their Q3 2026 earnings. Now, they aren't breaking any land speed records, but what they are doing is consistently stepping up their game, quarter by quarter, like clockwork. Drilling Down...
Continue ReadingTop 5 Most Recently Viewed Articles
Profiting from SPDR Gold MiniShares Trust: 5-Year Review
Understanding the SPDR Gold MiniShares Trust Performance SPDR Gold MiniShares Trust (NYSE: GLDM) has shown impressive returns over the past five years, outperforming the market by an average of 5.19% annually. With a market cap currently estimated at $25.61 billion, this fund has attracted the attention of investors looking to diversify their portfolios with gold. Initial...
Continue Reading
Ortel Announces Major Advancements in Laser Technology
Ortel's Strategic Move for Laser Fabrication Transfer Ortel, a prominent enterprise in photonics, has made headlines with the recent announcement regarding its wafer fabrication transfer for the C-Band High-Power Continuous Wave Laser Module platform. This significant shift to the Canadian Photonics Fabrication Centre (CPFC) marks a pivotal moment for the company,...
Continue Reading
GENFIT's GNS561 Aims to Revolutionize Cancer Treatment Options
Unveiling the Promise of GNS561 in Combination Therapy Recent findings from GENFIT have unveiled striking early results from an ongoing clinical study involving GNS561, an innovative investigational drug. The combination of GNS561 with a MEK inhibitor (MEKi) is showing encouraging potential, especially for patients suffering from KRAS mutated cholangiocarcinoma (CCA), a...
Continue Reading
Notable Shareholding Changes for Spar Nord Fonden Announced
Spar Nord Fonden's Major Shareholder Update Announcement Overview In a noteworthy step within the financial sector, Spar Nord Fonden has informed Spar Nord Bank A/S of an increase in its ownership. They've amassed a total of 23,853,707 shares, which represents 20.27% of Spar Nord Bank A/S's total share capital. This significant move not only showcases Spar Nord Fonden's...
Continue Reading
Equiduct Announces Martin Andersson as New Nordic Head
Martin Andersson Joins Equiduct as Head of Nordics Equiduct is excited to introduce Martin Andersson as the new Head of Nordics. With more than 25 years in financial markets, Martin brings expertise that promises to enhance Equiduct's vision and strategy within the Nordic region. A Wealth of Experience in Financial Markets Before joining Equiduct, Martin developed a...
Continue Reading